Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/204173
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Engineering the transmissible gastroenteritis virus genome as an expression vector inducing lactogenic immunity |
Autor: | Solá Gurpegui, Isabel CSIC ORCID ; Zúñiga Lucas, Sonia CSIC ORCID ; Balasch, Mònica; Plana-Durán, Joan; Enjuanes Sánchez, Luis CSIC ORCID | Fecha de publicación: | abr-2003 | Editor: | American Society for Microbiology | Citación: | Journal of Virology 77(7): 4357-4369 (2003) | Resumen: | The genome of the coronavirus transmissible gastroenteritis virus (TGEV) has been engineered as an expression vector with an infectious cDNA. The vector led to the efficient (≥40 μg/106 cells) and stable (≥20 passages) expression of a heterologous gene (green fluorescent protein [GFP]), driven by the transcription-regulating sequences (TRS) of open reading frame (ORF) 3a inserted in the site previously occupied by the nonessential ORFs 3a and 3b. Expression levels driven by this TRS were higher than those of an expression cassette under the control of regulating sequences engineered with the N gene TRS. The recombinant TGEV including the GFP gene was still enteropathogenic, albeit with a 10- to 102-fold reduction in enteric tissue growth. Interestingly, a specific lactogenic immune response against the heterologous protein has been elicited in sows and their progeny. The engineering of an additional insertion site for the heterologous gene between viral genes N and 7 led to instability and to a new genetic organization of the 3′ end of the recombinant viruses. As a consequence, a major species of subgenomic mRNA was generated from a TRS with the noncanonical core sequence 5′-CUAAAA-3′. Extension of the complementarity between the TRS and sequences at the 3′ end of the viral leader was associated with transcriptional activation of noncanonical core sequences. The engineered vector led to expression levels as high as those of well-established vectors and seems very promising for the development of vaccines and, possibly, for gene therapy. | Versión del editor: | http://dx.doi.org/10.1128/JVI.77.7.4357-4369.2003 | URI: | http://hdl.handle.net/10261/204173 | DOI: | 10.1128/JVI.77.7.4357-4369.2003 | Identificadores: | doi: 10.1128/JVI.77.7.4357-4369.2003 issn: 0022-538X e-issn: 1098-5514 pmid: 12634392 |
Aparece en las colecciones: | (CNB) Artículos (PTI Salud Global) Colección Especial COVID-19 |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,35 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
56
checked on 04-abr-2024
SCOPUSTM
Citations
69
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
67
checked on 28-feb-2024
Page view(s)
235
checked on 19-abr-2024
Download(s)
32
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.